应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06821 凯莱英
休市中 04-19 16:08:35
57.600
-2.400
-4.00%
最高
60.950
最低
57.550
成交量
6.87万
今开
60.500
昨收
60.000
日振幅
5.67%
总市值
212.82亿
流通市值
15.87亿
总股本
3.69亿
成交额
400.20万
换手率
0.25%
流通股本
2,755万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
凯莱英(06821)4月19日斥资4458.15万元回购58.08万股A股
智通财经 · 04-19 20:41
凯莱英(06821)4月19日斥资4458.15万元回购58.08万股A股
潘龙玲2024年一季度表现,建信食品饮料行业股票A基金季度涨幅2.08%
证券之星 · 04-19 12:57
潘龙玲2024年一季度表现,建信食品饮料行业股票A基金季度涨幅2.08%
李佳存2024年一季度表现,招商医药健康产业股票基金季度跌幅11.59%
证券之星 · 04-19 12:57
李佳存2024年一季度表现,招商医药健康产业股票基金季度跌幅11.59%
【浙商医药||孙建】凯莱英:商业化强支撑,新兴业务蓄势待发
杏林建研 · 04-18 22:01
【浙商医药||孙建】凯莱英:商业化强支撑,新兴业务蓄势待发
凯莱英(06821)4月18日耗资约999.47万元回购12.74万股A股
智通财经 · 04-18 18:29
凯莱英(06821)4月18日耗资约999.47万元回购12.74万股A股
凯莱英:多肽产能预计到6月底达14250L
界面 · 04-18 15:51
凯莱英:多肽产能预计到6月底达14250L
凯莱英(06821.HK)拟4月22日在全景网举办2023年度业绩说明会
格隆汇资讯 · 04-17 19:59
凯莱英(06821.HK)拟4月22日在全景网举办2023年度业绩说明会
凯莱英:业绩说明会定于4月22日举行
每日经济新闻 · 04-17 16:47
凯莱英:业绩说明会定于4月22日举行
北向资金4月16日净买入凯莱英51.64万股 连续3日增持
自选股智能写手 · 04-17 09:30
北向资金4月16日净买入凯莱英51.64万股 连续3日增持
医疗服务行业盘中跳水,凯莱英跌0.59%
自选股智能写手 · 04-16
医疗服务行业盘中跳水,凯莱英跌0.59%
凯莱英:公司固定资产投资涵盖了包括小分子业务及各项新兴业务领域
证券之星 · 04-15
凯莱英:公司固定资产投资涵盖了包括小分子业务及各项新兴业务领域
凯莱英(06821)4月15日斥资1999.7万元回购25.83万股A股
智通财经 · 04-15
凯莱英(06821)4月15日斥资1999.7万元回购25.83万股A股
凯莱英(06821.HK)4月25日举行董事会会议考虑及批准一季度业绩
格隆汇资讯 · 04-15
凯莱英(06821.HK)4月25日举行董事会会议考虑及批准一季度业绩
凯莱英04月15日主力资金流入68万元 连续3日加仓
自选股智能写手 · 04-15
凯莱英04月15日主力资金流入68万元 连续3日加仓
凯莱英斥资2952.20万元回购38.22万股A股,彰显发展信心
和讯网 · 04-12
凯莱英斥资2952.20万元回购38.22万股A股,彰显发展信心
凯莱英(06821)4月12日斥资2952.2万元回购38.22万股
智通财经 · 04-12
凯莱英(06821)4月12日斥资2952.2万元回购38.22万股
凯莱英04月12日获主力加仓55万元 环比增加816.67%
自选股智能写手 · 04-12
凯莱英04月12日获主力加仓55万元 环比增加816.67%
凯莱英(002821)4月11日主力资金净卖出530.35万元
证券之星 · 04-12
凯莱英(002821)4月11日主力资金净卖出530.35万元
凯莱英(06821)4月11日斥资4999.56万元回购62.89万股A股
智通财经 · 04-11
凯莱英(06821)4月11日斥资4999.56万元回购62.89万股A股
凯莱英获Norges Bank增持19.33万股 每股作价约61.23港元
新浪港股 · 04-11
凯莱英获Norges Bank增持19.33万股 每股作价约61.23港元
加载更多
公司概况
公司名称:
凯莱英
所属市场:
SEHK
上市日期:
--
主营业务:
凯莱英医药集团(天津)股份有限公司是一家主要从事药物定制研发生产(CDMO)的中国公司。该公司的主营业务是化学药物的工艺开发、放大和商业化,产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司还从事药物制剂解决方案、生物合成解决方案和临床解决方案的提供。
发行价格:
--
{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":57.6,"timestamp":1713514115037,"preClose":60,"halted":0,"volume":68680,"delay":0,"floatShares":27553260,"shares":369471533,"eps":6.7637715,"marketStatus":"休市中","marketStatusCode":7,"change":-2.4,"latestTime":"04-19 16:08:35","open":60.5,"high":60.95,"low":57.55,"amount":4002020,"amplitude":0.056667,"askPrice":57.7,"askSize":3300,"bidPrice":57.6,"bidSize":3300,"shortable":3,"etf":0,"ttmEps":6.763771728486938,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1639065600000,"adjPreClose":60,"dividendRate":0.03376,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.764783,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":76.6,"timestamp":1713510195000,"preClose":78.41,"halted":0,"volume":4854712,"delay":0,"premium":"-30.40"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2428656469","title":"凯莱英(06821)4月19日斥资4458.15万元回购58.08万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428656469","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428656469?lang=zh_cn&edition=full","pubTime":"2024-04-19 20:41","pubTimestamp":1713530502,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2024年4月19日,该公司斥资人民币4458.15万元回购58.08万股A股,每股回购价为75.98-77元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105771.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428504417","title":"潘龙玲2024年一季度表现,建信食品饮料行业股票A基金季度涨幅2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428504417","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428504417?lang=zh_cn&edition=full","pubTime":"2024-04-19 12:57","pubTimestamp":1713502664,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2024年一季度末,基金经理潘龙玲旗下共管理5只基金,本季度表现最佳的为建信食品饮料行业股票A,季度净值涨2.08%。潘龙玲在担任建信高端医疗股票A基金经理的任职期间累计任职回报45.75%,平均年化收益率为5.73%。持有期间的估算收益率为195.91%,持有期间凯莱英在2018年到2020年的年报营业总收入增幅达71.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041900022307.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428504441","title":"李佳存2024年一季度表现,招商医药健康产业股票基金季度跌幅11.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428504441","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428504441?lang=zh_cn&edition=full","pubTime":"2024-04-19 12:57","pubTimestamp":1713502636,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2024年一季度末,基金经理李佳存旗下共管理9只基金,本季度表现最佳的为招商医药健康产业股票,季度净值跌11.59%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041900022283.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428900590","title":"【浙商医药||孙建】凯莱英:商业化强支撑,新兴业务蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2428900590","media":"杏林建研","top":-1,"share":"https://www.laohu8.com/m/news/2428900590?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:01","pubTimestamp":1713448890,"startTime":"0","endTime":"0","summary":"投资要点2023年CDMO和新兴业务均快速增长,商业化项目收入YOY支撑强,看好新兴业务蓄势待发。2023年公司确认收入的商业化项目40 个,实现收入 51.12 亿元,剔除大订单后收入 26.92 亿元,同比增长47.13%;显示出商业化项目收入对2023年收入较强的支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182206118790b2b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182206118790b2b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428394566","title":"凯莱英(06821)4月18日耗资约999.47万元回购12.74万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428394566","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428394566?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:29","pubTimestamp":1713436154,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)公布,2024年4月18日耗资约999.47万元回购12.74万股A股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104698.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428376556","title":"凯莱英:多肽产能预计到6月底达14250L","url":"https://stock-news.laohu8.com/highlight/detail?id=2428376556","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2428376556?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:51","pubTimestamp":1713426674,"startTime":"0","endTime":"0","summary":"凯莱英4月18日在互动平台表示,多肽业务是公司的战略重点,公司加快多肽商业化产能建设,预计到2024年6月底达到14250L,以满足商业化项目需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418155114792171d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418155114792171d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428312678","title":"凯莱英(06821.HK)拟4月22日在全景网举办2023年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2428312678","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428312678?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:59","pubTimestamp":1713355146,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨凯莱英公告,凯莱英医药集团(天津)股份有限公司于2024年3月29日披露了2023年年度报告全文及摘要。为便于投资者能够进一步了解公司2023年度的经营情况,公司定于2024年4月22日(星期一)15:00-16:00在全景网举办2023年度业绩说明会。本次年度业绩说明会将采用网络远程的方式举行,公司通过文字直播方式回复投资者提问,投资者可登录全景网“投资者关系互动平台”参与本次年度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417195916878947e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417195916878947e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428999983","title":"凯莱英:业绩说明会定于4月22日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2428999983","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428999983?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:47","pubTimestamp":1713343671,"startTime":"0","endTime":"0","summary":"凯莱英(SZ002821,收盘价:78.32元)4月17日晚间发布公告称,公司2023年年度业绩说明会定于2024年4月22日(星期一)15:00-16:00,以网络远程的形式进行。出席本次业绩说明会的人员有:公司董事长、首席执行官HAOHONG,执行董事、首席运营官、首席财务官张达,高级副总裁兼董事会秘书徐向科,独立非执行董事孙雪娇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404173048830471.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404173048830471.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428373793","title":"北向资金4月16日净买入凯莱英51.64万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428373793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428373793?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:30","pubTimestamp":1713317456,"startTime":"0","endTime":"0","summary":"4月16日, 北向资金增持凯莱英51.64万股,连续3日增持。截止当日收盘,深股通共持有凯莱英1487.43万股,占流通股4.35%。深股通增持金额前五个股分别为长安汽车、思源电气、光启技术、藏格矿业、云南铜业。凯莱英近5个交易日下跌8.38%,深股通累计减持3.55万股;近20个交易日下跌24.02%,深股通累计减持393.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417094312878691d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417094312878691d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427868387","title":"医疗服务行业盘中跳水,凯莱英跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427868387","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427868387?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:39","pubTimestamp":1713231546,"startTime":"0","endTime":"0","summary":"04月16日,医疗服务行业盘中跳水,截至09点39分,医疗服务行业整体指数下跌1.01%,报4566.080点。从个股上来看,该行业的成分股中,凯莱英跌0.59%,爱尔眼科、金域医学、康龙化成跌幅居前。从资金上来看,截止发稿,医疗服务行业主力净流入为-6598.07万,其中泰格医药受到资金热捧,主力净流入315.19万;拉长时间线来看,该板块近20日主力资金净流入-158.45亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160939067920bc82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160939067920bc82&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427240750","title":"凯莱英:公司固定资产投资涵盖了包括小分子业务及各项新兴业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2427240750","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2427240750?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:27","pubTimestamp":1713173264,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英04月15日在投资者关系平台上答复投资者关心的问题。公司固定资产投资涵盖了包括小分子业务及各项新兴业务领域。投资者:尊敬的董秘,根据年报:“截至本报告披露日,剔除本报告期已确认收入的订单金额,公司在手订单总额 8.74 亿美元”。关于2024年第一季度以及未来长期经营情况,请持续关注公司后续披露的相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041500016158.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024134","title":"凯莱英(06821)4月15日斥资1999.7万元回购25.83万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024134","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427024134?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:25","pubTimestamp":1713173137,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2024年4月15日该公司斥资人民币1999.7万元回购25.83万股A股,每股回购价格为人民币76.78-77.75元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102570.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427026081","title":"凯莱英(06821.HK)4月25日举行董事会会议考虑及批准一季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2427026081","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427026081?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:48","pubTimestamp":1713170926,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨凯莱英(06821.HK)公布,董事会会议将于2024年4月25日(星期四)举行,藉以(其中包括)考虑及批准公司及其附属公司截至2024年3月31日止三个月的第一季度业绩及其发布,并考虑建议派发股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151648528b254889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151648528b254889&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427023061","title":"凯莱英04月15日主力资金流入68万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427023061","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427023061?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168982,"startTime":"0","endTime":"0","summary":"04月15日, 凯莱英股价跌1.81%,报收59.60元,成交金额855万元,换手率0.52%,振幅3.29%,量比0.73。凯莱英今日主力资金净流入68万元,连续3日净流入,上一交易日主力净流入55万元,今日环比增加23.64%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为20.00%,平均涨幅为1.19%。该股近5个交易日下跌1.81%,主力资金累计净流入84万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入285万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161639877e8eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161639877e8eac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426780768","title":"凯莱英斥资2952.20万元回购38.22万股A股,彰显发展信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2426780768","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2426780768?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:25","pubTimestamp":1712928330,"startTime":"0","endTime":"0","summary":"快讯摘要凯莱英于4月12日斥资2952.20万元回购38.22万股A股,彰显公司对自身价值的信心及对未来发展的积极预期。和讯自选股写手风险提示:以上内容仅作为作者或者嘉宾的观点,不代表和讯的任何立场,不构成与和讯相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213431876f4949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213431876f4949&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426054392","title":"凯莱英(06821)4月12日斥资2952.2万元回购38.22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426054392","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426054392?lang=zh_cn&edition=full","pubTime":"2024-04-12 17:14","pubTimestamp":1712913293,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2024年4月12日该公司斥资人民币2952.2万元回购38.22万股股份,每股回购价格为人民币76.68-77.65元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101736.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426277780","title":"凯莱英04月12日获主力加仓55万元 环比增加816.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426277780","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426277780?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:15","pubTimestamp":1712909737,"startTime":"0","endTime":"0","summary":"04月12日, 凯莱英股价跌1.70%,报收60.70元,成交金额648万元,换手率0.39%,振幅2.59%,量比0.58。凯莱英今日主力资金净流入55万元,上一交易日主力净流入6万元,今日环比增加816.67%。该股近5个交易日上涨3.98%,主力资金累计净流入267万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入216万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121616168b15cf98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121616168b15cf98&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426249085","title":"凯莱英(002821)4月11日主力资金净卖出530.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426249085","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426249085?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:34","pubTimestamp":1712885660,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月11日收盘,凯莱英报收于79.44元,下跌2.17%,换手率1.84%,成交量6.03万手,成交额4.79亿元。近5日资金流向一览见下表:凯莱英融资融券信息显示,融资方面,当日融资买入3910.32万元,融资偿还4464.15万元,融资净偿还553.83万元。融券方面,融券卖出4300.0股,融券偿还3220.0股,融券余量45.14万股,融券余额3586.3万元。凯莱英主营业务:是一家全球领先、技术驱动型的医药外包服务一站式综合服务商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041200014145.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426268458","title":"凯莱英(06821)4月11日斥资4999.56万元回购62.89万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268458","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426268458?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:59","pubTimestamp":1712843941,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2024年4月11日该公司斥资人民币4999.56万元回购62.89万股A股,回购价格为每股人民币78.8-80.0元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101418.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426871372","title":"凯莱英获Norges Bank增持19.33万股 每股作价约61.23港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426871372","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426871372?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:05","pubTimestamp":1712822710,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,4月8日,Norges Bank增持凯莱英(06821)19.33万股,每股作价61.2257港元,总金额约1183.49万港元。增持后最新持股数目为156.62万股,最新持股比例为5.68%。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-11/doc-inarmxxs1001493.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-11/doc-inarmxxs1001493.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":-0.0511},{"period":"1month","weight":-0.1529},{"period":"3month","weight":-0.2185},{"period":"6month","weight":-0.488},{"period":"1year","weight":-0.4352},{"period":"ytd","weight":-0.367}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团(天津)股份有限公司是一家主要从事药物定制研发生产(CDMO)的中国公司。该公司的主营业务是化学药物的工艺开发、放大和商业化,产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司还从事药物制剂解决方案、生物合成解决方案和临床解决方案的提供。","exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}